Introducing inulin-type fructans - PubMed (original) (raw)
Review
. 2005 Apr:93 Suppl 1:S13-25.
doi: 10.1079/bjn20041350.
Affiliations
- PMID: 15877886
- DOI: 10.1079/bjn20041350
Review
Introducing inulin-type fructans
Marcel B Roberfroid. Br J Nutr. 2005 Apr.
Abstract
Inulin is a generic term to cover all beta(2-->1) linear fructans. Chicory inulin is a linear beta(2-->1) fructan (degree of polymerisation (DP) 2 to 60; DPav=12), its partial enzymatic hydrolysis product is oligofructose (DP 2 to 8; DPav=4), and by applying specific separation technologies a long-chain inulin known as inulin HP (DP 10 to 60; DPav=25) can be produced. Finally, a specific product known as oligofructose-enriched inulin is obtained by combining chicory long-chain inulin and oligofructose. Because of the beta-configuration of the anomeric C2 in their fructose monomers, inulin-type fructans resist hydrolysis by intestinal digestive enzymes, they classify as 'non-digestible' carbohydrates, and they are dietary fibres. By increasing faecal biomass and water content of the stools, they improve bowel habits, but they have characteristic features different from other fibres. They affect gastrointestinal functions not because of their physico-chemical properties but rather because of their biochemical and physiological attributes. In the colon, they are rapidly fermented to produce SCFA that are good candidates to explain some of the systemic effects of inulin-type fructans. Fermentation of inulin-type fructans in the large bowel is a selective process; bifidobacteria (and possibly a few other genera) are preferentially stimulated to grow, thus causing significant changes in the composition of the gut microflora by increasing the number of potentially health-promoting bacteria and reducing the number of potentially harmful species. Both oligofructose and inulin are prebiotic. They also induce changes in colonic epithelium stimulating proliferation in the crypts, increasing the concentration of polyamines, changing the profile of mucins, and modulating endocrine as well as immune functions. From a nutrition labelling perspective, inulin-type fructans are not only prebiotic dietary fibres; they are also low-calorie carbohydrates [6.3 kJ/g (1.5 kcal/g)]. Supported by the results of a large number of animal studies and human nutrition intervention trials, the claim 'inulin-type fructans enhance calcium and magnesium absorption' is scientifically substantiated, but different inulin-type fructans have probably a different efficacy (in terms of effective daily dose), the most active product being the oligofructose-enriched inulin. A series of animal studies demonstrate that inulin-type fructans affect the metabolism of lipids primarily by decreasing triglyceridaemia because of a reduction in the number of plasma VLDL particles. The human data largely confirm the animal experiments. They demonstrate mainly a reduction in triglyceridaemia and only a relatively slight decrease in cholesterolaemia mostly in (slightly) hypertriglyceridaemic conditions. Inulin appears thus eligible for an enhanced function claim related to normalization of blood triacylglycerols. A large number of animal data convincingly show that inulin-type fructans reduce the risk of colon carcinogenesis and nutrition intervention trials are now performed to test that hypothesis in human subjects known to be at risk for polyps and cancer development in the large bowel.
Similar articles
- Inulin-type fructans: functional food ingredients.
Roberfroid MB. Roberfroid MB. J Nutr. 2007 Nov;137(11 Suppl):2493S-2502S. doi: 10.1093/jn/137.11.2493S. J Nutr. 2007. PMID: 17951492 Review. - Dietary fiber, inulin, and oligofructose: a review comparing their physiological effects.
Roberfroid M. Roberfroid M. Crit Rev Food Sci Nutr. 1993;33(2):103-48. doi: 10.1080/10408399309527616. Crit Rev Food Sci Nutr. 1993. PMID: 8257475 Review. - Inulin-type fructans and reduction in colon cancer risk: review of experimental and human data.
Pool-Zobel BL. Pool-Zobel BL. Br J Nutr. 2005 Apr;93 Suppl 1:S73-90. doi: 10.1079/bjn20041349. Br J Nutr. 2005. PMID: 15877900 Review. - Inulin, oligofructose and intestinal function.
Jenkins DJ, Kendall CW, Vuksan V. Jenkins DJ, et al. J Nutr. 1999 Jul;129(7 Suppl):1431S-3S. doi: 10.1093/jn/129.7.1431S. J Nutr. 1999. PMID: 10395613 Review. - Experimental evidences on the potential of prebiotic fructans to reduce the risk of colon cancer.
Pool-Zobel B, van Loo J, Rowland I, Roberfroid MB. Pool-Zobel B, et al. Br J Nutr. 2002 May;87 Suppl 2:S273-81. doi: 10.1079/BJNBJN/2002548. Br J Nutr. 2002. PMID: 12088529 Review.
Cited by
- Functionality of Agave Bagasse as Supplement for the Development of Prebiotics-Enriched Foods.
Escobedo-García S, Salas-Tovar JA, Flores-Gallegos AC, Contreras-Esquivel JC, González-Montemayor ÁM, López MG, Rodríguez-Herrera R. Escobedo-García S, et al. Plant Foods Hum Nutr. 2020 Mar;75(1):96-102. doi: 10.1007/s11130-019-00785-z. Plant Foods Hum Nutr. 2020. PMID: 31853903 - Effect of a synbiotic yogurt on levels of fecal bifidobacteria, clostridia, and enterobacteria.
Palaria A, Johnson-Kanda I, O'Sullivan DJ. Palaria A, et al. Appl Environ Microbiol. 2012 Feb;78(4):933-40. doi: 10.1128/AEM.05848-11. Epub 2011 Nov 18. Appl Environ Microbiol. 2012. PMID: 22101054 Free PMC article. Clinical Trial. - Oligosaccharides production from coprophilous fungi: An emerging functional food with potential health-promoting properties.
Ojwach J, Adetunji AI, Mutanda T, Mukaratirwa S. Ojwach J, et al. Biotechnol Rep (Amst). 2022 Jan 21;33:e00702. doi: 10.1016/j.btre.2022.e00702. eCollection 2022 Mar. Biotechnol Rep (Amst). 2022. PMID: 35127459 Free PMC article. Review. - Evaluation of Full-Length Versus V4-Region 16S rRNA Sequencing for Phylogenetic Analysis of Mouse Intestinal Microbiota After a Dietary Intervention.
Katiraei S, Anvar Y, Hoving L, Berbée JFP, van Harmelen V, Willems van Dijk K. Katiraei S, et al. Curr Microbiol. 2022 Jul 30;79(9):276. doi: 10.1007/s00284-022-02956-9. Curr Microbiol. 2022. PMID: 35907023 Free PMC article. - Use of fiber instead of laxative treatment in a geriatric hospital to improve the wellbeing of seniors.
Sturtzel B, Mikulits C, Gisinger C, Elmadfa I. Sturtzel B, et al. J Nutr Health Aging. 2009 Feb;13(2):136-9. doi: 10.1007/s12603-009-0020-2. J Nutr Health Aging. 2009. PMID: 19214342 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous